Peter Fleming
Impact in
- Endocrinology top 0.2%
- Escherichia coli research studies
- Vibrio bacteria research studies
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 12
- Pneumonia and Respiratory Infections 7
-
- Cystic Fibrosis Research Advances 4
- Co-authors
- Mohamed A. Karmali (12 shared papers)H. Lior (1 shared paper)Corazon Lim (1 shared paper)Henry Levison (4 shared papers)Ronald Gold (3 shared papers)Mary Corey (2 shared papers)Alan Isles (2 shared papers)Ian MacLusky (1 shared paper)
- Journals
- The Journal of Pediatrics (4 papers)Journal of Clinical Microbiology (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)The Lancet (3 papers)Journal of Bacteriology (2 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Peter Fleming
41 papers receiving 2.9k citations
Peter Fleming's Hit Papers
Peers
Comparison fields: 5 of 119
- Endocrinology 1.3k
- Molecular Medicine 400
- Infectious Diseases 1.2k
- Food Science 705
- Biotechnology 296
Countries citing papers authored by Peter Fleming
This map shows the geographic impact of Peter Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fleming more than expected).
Fields of papers citing papers by Peter Fleming
This network shows the impact of papers produced by Peter Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fleming. The network helps show where Peter Fleming may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli Hit paper breakdown → | 1985 | 1139 |
| 2 | Pseudomonas cepacia infection in cystic fibrosis: An emerging problem Hit paper breakdown → | 1984 | 709 |
| 3 | 1979 | 193 | |
| 4 | 1981 | 90 | |
| 5 | 1963 | 88 | |
| 6 | 1986 | 87 | |
| 7 | 1982 | 82 | |
| 8 | 1981 | 74 | |
| 9 | 1996 | 68 | |
| 10 | 1983 | 62 | |
| 11 | 1983 | 61 | |
| 12 | 1985 | 61 | |
| 13 | 1982 | 56 | |
| 14 | 1980 | 43 | |
| 15 | Ampicillin-Resistant Strains of Hemophilus influenzae type B : Committee on Infectious Diseases | 1975 | 42 |
| 16 | 1960 | 40 | |
| 17 | 2011 | 38 | |
| 18 | Ampicillin in the treatment of bacterial meningitis. | 1966 | 31 |
| 19 | 1981 | 27 | |
| 20 | Febrile mucocutaneous syndrome with respiratory involvement, associated with isolation of Mycoplasma pneumoniae. | 1967 | 24 |
About Peter Fleming
Peter Fleming is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Molecular Medicine, Infectious Diseases and Microbiology, having authored 42 papers that have together received 3.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Salmonella and Campylobacter epidemiology (8 papers), Pneumonia and Respiratory Infections (7 papers), Bacterial Infections and Vaccines (7 papers), Cystic Fibrosis Research Advances (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Enterobacteriaceae and Cronobacter Research (3 papers) and Viral gastroenteritis research and epidemiology (3 papers). The work is most often cited by research in Endocrinology (1.3k citations), Molecular Medicine (400 citations), Infectious Diseases (1.2k citations), Food Science (705 citations) and Biotechnology (296 citations). Peter Fleming has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Mohamed A. Karmali, H. Lior, Corazon Lim, Henry Levison, Ronald Gold, Mary Corey, Alan Isles, Ian MacLusky, Charles G. Prober and M. Goldner. Their work appears in journals such as The Journal of Pediatrics, Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, The Lancet and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.